. 2021 Mar 15;11:5936. doi: 10.1038/s41598-021-85323-1

Table 2.

Comparison of test results for the Rec-ELISA using rNP, rMLD, and rNP/rMLD probed with sera of convalescent phase CCHF patients (n: 35).

Antigens	Results	Groups		P value	Odds ratio (95% CI)
Antigens	Results	Convalescent CCHF (n = 35)	Control (n = 43)	P value	Odds ratio (95% CI)
rMLD	Positive	31 (88.6%)	1 (2.3%)	< 0.0001	326.0 (34.6–3059.0)
rMLD	Negative	4 (11.4%)	42 (97.7%)	< 0.0001	326.0 (34.6–3059.0)
rNP	Positive	34 (97.2%)	1 (2.3%)	< 0.0001	1428.0 (76.0 – 23,699)
rNP	Negative	1 (2.8%)	42 (97.7%)	< 0.0001	1428.0 (76.0 – 23,699)
rNP/rMLD	Positive	34 (97.2%)	1 (2.3%)	< 0.0001	1428.0 (76.0 – 23,699)
rNP/rMLD	Negative	1 (2.8%)	42 (97.7%)	< 0.0001	1428.0 (76.0 – 23,699)

CI confidence interval.

Bold values are statistically significant for P <0.05.